FDA Adverse Event Injury Summary report: N

GORE® VIABAHN® ENDOPROSTHESIS

MDR report key: 14882109 · Received June 30, 2022

Report

Report Number
2017233-2022-03086
Event Type
Injury
Date Received
June 30, 2022
Date of Event
January 11, 2020
Report Date
August 2, 2022
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
NIP
PMA / PMN Number
P040037
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CBAS® HEPARIN SURFACE INCORPORATES CARMEDA HEPARIN MANUFACTURED FROM HEPARIN SODIUM API, WHICH IS COVALENTLY BOUND TO THE DEVICE SURFACE AND IS ESSENTIALLY NON-ELUTING.

Additional Manufacturer Narrative · 0

REMOVE C1. H6: 213-DUE TO AN UNKNOWN LOT/SERIAL NUMBER AND NO DEVICE RETURN, AN INVESTIGATION COULD NOT BE PERFORMED. CITATION: JUN BAI, YANDONG LIU, JIE JIN, JIANJIN WU. MID-TERM RESULTS OF IN SITU FENESTRATION STENTED WITH BALLOON-EXPANDABLE BARE METAL STENTS DURING THORACIC ENDOVASCULAR AORTIC REPAIR. CATHETER CARDIOVASC INTERV. 2020; 95:1163¿1168. DOI: 10.1002/CCD.28743.

Description of Event or Problem · 0

THE FOLLOWING INFORMATION WAS RECEIVED THROUGH LITERATURE ¿MID-TERM RESULTS OF IN SITU FENESTRATION STENTED WITH BALLOON-EXPANDABLE BARE METAL STENTS DURING THORACIC ENDOVASCULAR AORTIC REPAIR¿ PUBLISHED BY CATHETER CARDIOVASC INTERV. 2020; 95:1163¿1168. THE STUDY WAS TO ASSESS THE SAFETY, FEASIBILITY AND EFFECTIVENESS OF BALLOON-EXPANDABLE BARE METAL STENTS (BMS) AS BRIDGE STENTS DURING THORACIC ENDOVASCULAR AORTIC REPAIR (TEVAR). THE RESULTS STATE IN THE SERIES, ONE CASE WITH AN 8*50 MM VIABAHN®-COVERED STENT HAD A 50% RESIDUAL STENOSIS IN THE CONNECTING PART OF AORTIC GRAFT AND BRIDGING STENT AFTER PRE-DILATION. THE STENOSIS WAS NOT RESOLVED AFTER SEVERAL DILATIONS, BUT IT WAS RESOLVED AFTER ANOTHER 8*37-MM BALLOON-EXPANDABLE BARE STENT WAS INSERTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2009159 GORE® VIABAHN® ENDOPROSTHESIS STENT, SUPERFICIAL FEMORAL ARTERY NIP W. L. GORE & ASSOCIATES, INC.

Patients

Seq Age Sex Outcome Treatment
1 62 YR Male Required Intervention